By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation and analyze site usage. This site uses cookies as described in our Privacy Policy and Terms of Use.
Welcome to Roivant
Eyes

Reinventing the discovery, development, and commercialization of new medicines

About Us

We develop transformative medicines and technologies by building agile, focused companies called Vants.

Learn about us
  • 10

    positive Phase 3 trials since 2019

    • 01
    02
    Our companies

    Our model aligns incentives to drive fast, high-quality execution and rigorous capital allocation.

    We employ technology across discovery, development, and commercialization.

     

    Learn about our companies
    Immunovant

    Immunovant

    Advancing potentially transformative therapies for autoimmune diseases

    priovant

    Priovant

    Developing targeted therapies for patients with severe autoimmune disease

    Pulmovant Card

    Pulmovant

    Committed to transforming the lives of patients with pulmonary diseases

    video section decoration

    About Roivant

    For Investors
    For Investors

    Learn more about our work

    Sign up for our latest announcements and upcoming presentations

    Read more
    Pipeline
    Pipeline

    Advancing medicines that matter

    View our broad and differentiated pipeline of investigational drugs.

    Read more